Literature DB >> 30083784

Identification of Critical Genes and miRNAs Associated with the Development of Parkinson's Disease.

Jia Li1, Yajuan Sun1, Jiajun Chen2.   

Abstract

The purpose of this study was to explore the key mechanism involved in the pathogenesis of Parkinson's disease (PD) based on microarray analysis. The expression profile data of GSE7621, which contained 9 substantia nigra tissues isolated from normals and 16 substantia nigra tissues isolated from PD patients, was obtained from Gene Expression Omnibus. The differentially expressed genes (DEGs) were screened, followed by functional enrichment analysis and protein-protein interaction (PPI) network construction. After the miRNAs regulating the DEGs were predicted, the miRNA-DEG regulatory network was then constructed. Besides, the 6-hydroxydopamine rat model of PD was established and the expression of key DEGs and miRNA was detected. A total of 388 DEGs were identified, including 218 upregulated genes and 170 downregulated ones. Tyrosine hydroxylase (TH) and solute carrier family 6 member 3 (SLC6A3) were significantly related to the functional terms of catecholamine biosynthetic process and dopamine biosynthetic process. TH and SLC6A3 were hub nodes in the PPI network. EBF3 could be targeted by miR-218. Moreover, TH and SLC6A3 were found downregulated in the 6-OHDA rat model of PD, while miR-218 was markedly upregulated. Our results reveal that SLC6A3, TH, and EBF3 targeted by miR-218 could be involved in PD. These molecules might provide a new insight into the development of therapeutic strategies for PD.

Entities:  

Keywords:  Differentially expressed genes; Module analysis; Parkinson’s disease; Protein-protein interaction network; microRNAs

Mesh:

Substances:

Year:  2018        PMID: 30083784     DOI: 10.1007/s12031-018-1129-8

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  34 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Complex segregation analysis of Parkinson's disease: The Mayo Clinic Family Study.

Authors:  Shannon K McDonnell; Daniel J Schaid; Alexis Elbaz; Kari J Strain; James H Bower; J Eric Ahlskog; Demetrius M Maraganore; Walter A Rocca
Journal:  Ann Neurol       Date:  2006-05       Impact factor: 10.422

3.  Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Authors:  Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

4.  Detecting overlapping protein complexes in protein-protein interaction networks.

Authors:  Tamás Nepusz; Haiyuan Yu; Alberto Paccanaro
Journal:  Nat Methods       Date:  2012-03-18       Impact factor: 28.547

5.  Ebf2 is required for development of dopamine neurons in the midbrain periaqueductal gray matter of mouse.

Authors:  Qiaoqiao Yang; Shuxi Liu; Min Yin; Yanqing Yin; Guomin Zhou; Jiawei Zhou
Journal:  Dev Neurobiol       Date:  2015-03-20       Impact factor: 3.964

6.  Development of a microchip-pulsed electrochemical method for rapid determination of L-DOPA and tyrosine in Mucuna pruriens.

Authors:  Xinchun Li; Zuanguang Chen; Fan Yang; Jianbin Pan; Yinbao Li
Journal:  J Sep Sci       Date:  2013-04-24       Impact factor: 3.645

7.  A novel compound heterozygous tyrosine hydroxylase mutation (p.R441P) with complex phenotype.

Authors:  Kristoffer Haugarvoll; Laurence A Bindoff
Journal:  J Parkinsons Dis       Date:  2011       Impact factor: 5.568

8.  A travel guide to Cytoscape plugins.

Authors:  Rintaro Saito; Michael E Smoot; Keiichiro Ono; Johannes Ruscheinski; Peng-Liang Wang; Samad Lotia; Alexander R Pico; Gary D Bader; Trey Ideker
Journal:  Nat Methods       Date:  2012-11-06       Impact factor: 28.547

9.  Lanosterol induces mitochondrial uncoupling and protects dopaminergic neurons from cell death in a model for Parkinson's disease.

Authors:  L Lim; V Jackson-Lewis; L C Wong; G H Shui; A X H Goh; S Kesavapany; A M Jenner; M Fivaz; S Przedborski; M R Wenk
Journal:  Cell Death Differ       Date:  2011-08-05       Impact factor: 15.828

10.  Microarray analysis after RNA amplification can detect pronounced differences in gene expression using limma.

Authors:  Ilhem Diboun; Lorenz Wernisch; Christine Anne Orengo; Martin Koltzenburg
Journal:  BMC Genomics       Date:  2006-10-09       Impact factor: 3.969

View more
  5 in total

1.  miR-218-2 regulates cognitive functions in the hippocampus through complement component 3-dependent modulation of synaptic vesicle release.

Authors:  Si-Yao Lu; Chong-Lei Fu; Liang Liang; Bo Yang; Wei Shen; Qiu-Wen Wang; Yun Chen; Yan-Fen Chen; Yao-Nan Liu; Lin Zhu; Jieqing Zhao; Wei Shi; Shuangli Mi; Jun Yao
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-06       Impact factor: 11.205

Review 2.  The Essential Role of Epigenetic Modifications in Neurodegenerative Diseases with Dyskinesia.

Authors:  Zhipeng Qi; Jiashuo Li; Minghui Li; Xianchao Du; Lei Zhang; Shuang Wang; Bin Xu; Wei Liu; Zhaofa Xu; Yu Deng
Journal:  Cell Mol Neurobiol       Date:  2021-08-12       Impact factor: 4.231

Review 3.  Clinical Application of Circulating MicroRNAs in Parkinson's Disease: The Challenges and Opportunities as Diagnostic Biomarker.

Authors:  Palaniswamy Ramaswamy; Ravi Yadav; Pramod Kumar Pal; Rita Christopher
Journal:  Ann Indian Acad Neurol       Date:  2020-01-21       Impact factor: 1.383

Review 4.  The Role of the SLC Transporters Protein in the Neurodegenerative Disorders.

Authors:  Asli Ayka; Ahmet Özer Şehirli
Journal:  Clin Psychopharmacol Neurosci       Date:  2020-05-31       Impact factor: 2.582

5.  Weighted Gene Coexpression Network Analysis Uncovers Critical Genes and Pathways for Multiple Brain Regions in Parkinson's Disease.

Authors:  Jianjun Huang; Li Liu; Lingling Qin; Hehua Huang; Xue Li
Journal:  Biomed Res Int       Date:  2021-03-13       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.